Randomized Clinical Trials on Surrogate End Points: Are They Useful for Evaluating Cardiovascular and Renal Disease Protection in Hypertension? The Case for Yes-Reference-Cited by-同舟云学术

Randomized Clinical Trials on Surrogate End Points: Are They Useful for Evaluating Cardiovascular and Renal Disease Protection in Hypertension? The Case for Yes

Published:2006-03-24 Issue:4 suppl 2 Volume:17 Page:S141-S144
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Morganti Alberto

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference23 articles.

1. Left Ventricular Hypertrophy by Electrocardiogram

2. Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men

3. Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension

4. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

5. Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis;American Journal of Kidney Diseases;2016-10

2. Pathophysiologic therapeutic targets in hypertension: a cardiological point of view;Expert Opinion on Therapeutic Targets;2012-01-27

3. Changes in surrogate outcomes can be translated into clinical outcomes using a Monte Carlo model;Journal of Clinical Epidemiology;2009-12

4. Microbial nucleic acids pay a Toll in kidney disease;American Journal of Physiology-Renal Physiology;2006-09